Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109069393 | 10906939 | 3 | F | 20150220 | 20160713 | 20150312 | 20160718 | EXP | JP-ROCHE-1550387 | ROCHE | 65.00 | YR | F | Y | 0.00000 | 20160718 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109069393 | 10906939 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | 125156 | .05 | ML | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 109069393 | 10906939 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 125156 | .05 | ML | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109069393 | 10906939 | 1 | Macular oedema |
| 109069393 | 10906939 | 2 | Retinal vein occlusion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109069393 | 10906939 | OT |
| 109069393 | 10906939 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109069393 | 10906939 | Cataract | |
| 109069393 | 10906939 | Glaucoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109069393 | 10906939 | 1 | 201409 | 0 | ||
| 109069393 | 10906939 | 2 | 20150212 | 20150212 | 0 |